The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
Patients with stage III epithelial ovarian cancer (EOC) and no visible residual ... Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients ...
OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, today ...
Danelle Scalia never imagined that she would be fighting for her life against ovarian cancer at the age of just 41.But her ...
News Medical on MSN2d
Contraceptive pill could help reduce risk of ovarian cancer, study suggestsScreening for risk factors of ovarian cancer using artificial intelligence, UniSA researchers found that the oral ...
HealthDay on MSN6d
Could the Birth Control Pill Reduce Ovarian Cancer Risk?A new study suggests taking birth control pills can help lower the risk of ovarian cancer.Ovarian cancer is known as the ...
The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...
“Ovarian cancer is notoriously diagnosed at a late stage, with about 70% of cases only identified when they are significantly advanced,” Lumsden said. “Late detection contributes to a ...
Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback